Journal of the American Chemical Society
Article
New Frontiers in Asymmetric Catalysis; Mikamiand, K., Lautens, M.,
Eds.; Wiley: Hoboken, NJ, 2007; pp 275−309. (e) Atodiresei, I.;
Schiffers, I.; Bolm, C. Chem. Rev. 2007, 107, 5683. (f) García-Urdiales,
E.; Alfonso, I.; Gotor, V. Chem. Rev. 2011, 111, PR110.
(7) For using para-dienones (p-dienones) as a terminology for this
type of 4,4-disubstituted cyclohexa-2,5-dienones, see: (a) Burling, E.
D.; Jefferson, A.; Scheinmann, F. Tetrahedron 1965, 21, 2653.
(b) Regel, W.; von Philipsborn, W. Helv. Chim. Acta 1969, 52, 1354.
(c) Barton, D. H. R.; Magnus, P. D.; Pearson, M. J. Chem. Commun.
1969, 550.
(8) For recent reviews on asymmetric transformations of para-
́
dienones, see: (a) Maertens, G.; Menard, M.-A.; Canesi, S. Synthesis
2014, 46, 1573. (b) Kalstabakken, K. A.; Harned, A. M. Tetrahedron
2014, 70, 9571. (c) Yang, X.; Wang, J.; Li, P. Org. Biomol. Chem. 2014,
12, 2499.
(9) For examples on tandem reaction starting from para-dienones via
enantioselective desymmetrization, see: (a) Rubush, D. M.; Morges,
M. A.; Rose, B. J.; Thamm, D. H.; Rovis, T. J. Am. Chem. Soc. 2012,
134, 13554. (b) Tello-Aburto, R.; Kalstabakken, K. A.; Harned, A. M.
Org. Biomol. Chem. 2013, 11, 5596. (c) He, Z.-T.; Tian, B.; Fukui, Y.;
Tong, X.; Tian, P.; Lin, G.-Q. Angew. Chem., Int. Ed. 2013, 52, 5314.
(d) Keilitz, J.; Newman, S. G.; Lautens, M. Org. Lett. 2013, 15, 1148.
(e) Liu, P.; Fukui, Y.; Tian, P.; He, Z.-T.; Sun, C.-Y.; Wu, N.-Y.; Lin,
G.-Q. J. Am. Chem. Soc. 2013, 135, 11700. (f) Li, J.; Liu, G.-L.; Zhao,
X.-H.; Du, J.-Y.; Qu, H.; Chu, W.-D.; Ding, M.; Jin, C.-Y.; Wei, M.-X.;
Fan, C.-A. Chem.Asian J. 2013, 8, 1105. (g) Corbett, M. T.;
Johnson, J. S. Chem. Sci. 2013, 4, 2828. (h) Rubush, D. M.; Rovis, T.
Synlett 2014, 25, 713. For examples of one-pot reaction involving in
situ formed para-dienones via enantioselective desymmetrization, see:
(i) Vo, N. T.; Pace, R. D. M.; O’Hara, F.; Gaunt, M. J. J. Am. Chem.
Soc. 2008, 130, 404. (j) Ratnikov, M. O.; Farkas, L. E.; Doyle, M. P. J.
Org. Chem. 2012, 77, 10294.
(10) For recent examples on nontandem reaction of para-dienones
via enantioselective desymmetrization, see: (a) Kondo, K.; Sodeoka,
M.; Mori, M.; Shibasaki, M. Synthesis 1993, 1993, 920. (b) Imbos, R.;
Brilman, M. H. G.; Pineschi, M.; Feringa, B. L. Org. Lett. 1999, 1, 623.
(c) Imbos, R.; Minnaard, A. J.; Feringa, B. L. J. Am. Chem. Soc. 2002,
124, 184. (d) Imbos, R.; Minnaard, A. J.; Feringa, B. L. Dalton Trans.
2003, 2017. (e) Hayashi, Y.; Gotoh, H.; Tamura, T.; Yamaguchi, H.;
Masui, R.; Shoji, M. J. Am. Chem. Soc. 2005, 127, 16028. (f) Liu, Q.;
Rovis, T. J. Am. Chem. Soc. 2006, 128, 2552. (g) Gu, Q.; Rong, Z.-Q.;
Zheng, C.; You, S.-L. J. Am. Chem. Soc. 2010, 132, 4056. (h) Leon, R.;
Jawalekar, A.; Redert, T.; Gaunt, M. J. Chem. Sci. 2011, 2, 1487. (i) Gu,
Q.; You, S.-L. Chem. Sci. 2011, 2, 1519. (j) Gu, Q.; You, S.-L. Org. Lett.
2011, 13, 5192. (k) Tello-Aburto, R.; Kalstabakken, K. A.; Volp, K. A.;
Harned, A. M. Org. Biomol. Chem. 2011, 9, 7849. (l) Takizawa, S.;
Nguyen, T. M.-N.; Grossmann, A.; Enders, D.; Sasai, H. Angew. Chem.,
Int. Ed. 2012, 51, 5423. (m) Jia, M.-Q.; You, S.-L. Chem. Commun.
2012, 48, 6363. (n) Jia, M.-Q.; Liu, C.; You, S.-L. J. Org. Chem. 2012,
77, 10996. (o) Wu, W.; Li, X.; Huang, H.; Yuan, X.; Lu, J.; Zhu, K.; Ye,
J. Angew. Chem., Int. Ed. 2013, 52, 1743. (p) Liu, K.; Teng, H.-L.; Yao,
L.; Tao, H.-Y.; Wang, C.-J. Org. Lett. 2013, 15, 2250.
(14) For selected reviews on organocatalysis based on bifunctional
(thio)ureas and bifunctional squaramides, see: (a) Takemoto, Y. Org.
Biomol. Chem. 2005, 3, 4299. (b) Connon, S. J. Chem.Eur. J. 2006,
12, 5418. (c) Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed.
2006, 45, 1520. (d) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007,
107, 5713. (e) Connon, S. J. Chem. Commun. 2008, 2499. (f) Zhang,
Z.; Schreiner, P. R. Chem. Soc. Rev. 2009, 38, 1187. (g) Kotke, M.;
Schreiner, P. R. In Hydrogen Bonding in Organic Synthesis; Pihko, P. M.,
Ed.; Wiley-VCH: Weinheim, Germany, 2009; pp 141−351. (h) Ale-
man
́
, J.; Parra, A.; Jiang, H.; Jørgensen, K. A. Chem.Eur. J. 2011, 17,
6890. (i) Storer, R. I.; Aciro, C.; Jones, L. H. Chem. Soc. Rev. 2011, 40,
2330. (j) Jakab, G.; Schreiner, P. R. In Comprehensive Enantioselective
Organocatalysis; Dalko, P. I., Ed.; Wiley-VCH: Weinheim, Germany,
2013; pp 315−341. (k) Tsakos, M.; Kokotos, C. G. Tetrahedron 2013,
69, 10199. (l) Serdyuk, O. V.; Heckel, C. M.; Tsogoeva, S. B. Org.
Biomol. Chem. 2013, 11, 7051. (m) Auvil, T. J.; Schafer, A. G.;
Mattson, A. E. Eur. J. Org. Chem. 2014, 2633.
(15) For details on the condition optimization, see the Supporting
Information.
(16) For recent examples on asymmetric catalysis using 4a, see:
(a) Li, L.; Klauber, E. G.; Seidel, D. J. Am. Chem. Soc. 2008, 130,
12248. (b) Lu, R.-j.; Yan, Y.-y.; Wang, J.-j.; Du, Q.-s.; Nie, S.-z.; Yan,
M. J. Org. Chem. 2011, 76, 6230. (c) Bai, J.-F.; Wang, L.-L.; Peng, L.;
Guo, Y.-L.; Jia, L.-N.; Tian, F.; He, G.-Y.; Xu, X.-Y.; Wang, L.-X. J. Org.
Chem. 2012, 77, 2947. (d) Tripathi, C. B.; Mukherjee, S. Org. Lett.
2014, 16, 3368.
(17) The in situ formation of intermediate 3aa has been previously
proposed in a tandem protocol involving an uncontrollable aza-
Michael addition. For details, see: Pereira, J.; Barlier, M.; Guillou, C.
Org. Lett. 2007, 9, 3101.
(18) The constitutional structure arising from intramolecular aza-
Michael addition of the carbamate moiety was assigned on the basis of
the HMBC spectroscopy of 3aa. For details, see page S77 of
Supporting Information.
(19) The reaction enantioselectivity was assigned by analogy on the
basis of a later assignment of the absolute configuration of 3ab, which
was unequivocally established by X-ray crystallographic analysis of a
later-stage pentacyclic intermediate 9 (Scheme 5). Accordingly, a
model for the observed enantioselectivity was also proposed as below.
(20) In contrast to the positive results using substrates with bulky N-
alkoxycarbonyl group (e.g., R2 = Boc) in Table 1, the sulfonyl-
protected secondary aromatic amino group generated in situ as
nitrogen donor was not compatible for the enantioselectivity of our
bifunctional catalyzed tandem reaction. Notably, the sulfonyl-
protected secondary aliphatic amino group as nitrogen donor has
been successfully described by Gu and You in the cinchonine derived
thiourea-catalyzed asymmetric aza-Michael reaction (see ref 10i), but
the corresponding N-Boc-protected aliphatic amino group could not
act as an effective aza-Michael donor in that case.
(11) For recent reviews on asymmetric aza-Michael addition, see:
(a) Liu, M.; Sibi, M. P. Tetrahedron 2002, 58, 7991. (b) Xu, L.-W.; Xia,
C.-G. Eur. J. Org. Chem. 2005, 633. (c) Vicario, J. L.; Badía, D.;
Carrillo, L.; Etxebarria, J.; Reyes, E.; Ruiz, N. Org. Prep. Proced. Int.
2005, 37, 513. (d) Vicario, J. L.; Badía, D.; Carrillo, L. Synthesis 2007,
2065. (e) Krishna, P. R.; Sreeshailam, A.; Srinivas, R. Tetrahedron
2009, 65, 9657. (f) Enders, D.; Wang, C.; Liebich, J. X. Chem.Eur. J.
2009, 15, 11058. (g) Reyes, E.; Fernandez, M.; Uria, U.; Vicario, J. L.;
Badia, D.; Carrillo, L. Curr. Org. Chem. 2012, 16, 521. (h) Wang, J.; Li,
P.; Choy, P. Y.; Chan, A. S. C.; Kwong, F. Y. ChemCatChem 2012, 4,
917. (i) Amara, Z.; Caron, J.; Joseph, D. Nat. Prod. Rep. 2013, 30,
(21) (a) Hosokawa, T.; Aoki, S.; Takano, M.; Nakahira, T.; Yoshida,
Y.; Murahashi, S.-I. J. Chem. Soc., Chem. Commun. 1991, 20, 1559.
(b) Weiner, B.; Baeza, A.; Jerphagnon, T.; Feringa, B. L. J. Am. Chem.
́
Soc. 2009, 131, 9473. (c) Dong, J. J.; Harvey, E. C.; Fananas-Mastral,
̃
1211. (j) San
Pozo, C. Chem. Soc. Rev. 2014, 43, 7430.
́ ́ ́
chez-Rosello, M.; Acena, J. L.; Simon-Fuentes, A.; del
̃
M.; Browne, W. R.; Feringa, B. L. J. Am. Chem. Soc. 2014, 136, 17302.
For a recent review, see: (d) Dong, J. J.; Browne, W. R.; Feringa, B. L.
Angew. Chem., Int. Ed. 2014, 54, 734.
(12) Kan, C.; Husson, H.-P.; Jacquemin, H.; Kan, S.-K.; Lounasmaa,
M. Tetrahedron Lett. 1980, 21, 55.
(13) Medina, J. D.; Genova, L. D. Planta Med. 1979, 37, 165.
(22) (a) Rahman, A.-u.; Basha, A. In Biosynthesis of Indole Alkaloids;
Clarendon Press: Oxford, U.K., 1983. (b) Dewick, P. M. In Medicinal
F
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX